← Evidence map

RetractedArticleOncology letters2019

Serum miR-338-5p has potential for use as a tumor marker for retinoblastoma.

Peng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31289501